TB-500
Also known as: Thymosin Beta-4 fragment, TB4 fragment
Synthetic fragment of Thymosin Beta-4 active site. Studied for actin sequestration, cell migration, and tissue repair.
Who's worth your money for TB-500
Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.
Top Merit pick
Highest Merit Score (99) of 22 scored sellers
$490 · 100mg · 99.8% purity
Best value
Lowest $/mg among scored sellers
$340 · 100mg · 99.2% purity
Most tested
57 independent COAs on file
$62.00 · 10mg · 99.0% purity
Average price
$8.38/mg
Sellers
86
45-day trend
-1.7%
71 of 86 sellers have a current price· 19 stale hidden· 30 unverified hidden
Top Merit pick
🇺🇸 Peptide Partners99via Disclosed Labs · 23h ago
$4.90/mg -41.5% vs avg$490
100mg
- 🇺🇸 Glacier Aminos99
✓ verified at source · 23h ago
$5.90/mg -29.6% vs avg$58.99
10mg
- 🇺🇸 Moglabs96
via Disclosed Labs · 23h ago
$7.60/mg -9.3% vs avg$38.00
5mg
- 🇺🇸 BioLongevity Labs96
✓ verified at source · 23h ago
$16.50/mg +96.9% vs avg$165
10mg
- 🇺🇸 Orbitrex Peptides95
via Disclosed Labs · 23h ago
$6.00/mg -28.4% vs avg$59.99
10mg
- 🇺🇸 Profound Aminos95
via Disclosed Labs · 23h ago
$6.50/mg -22.4% vs avg$65.00
10mg
- 🇺🇸 Licensed Peptides95
✓ verified at source · 23h ago
$58.49/mg +598.2% vs avg$585
10mg
- 🇺🇸 Forge Performance Co.94
✓ verified at source · 23h ago
$6.00/mg -28.4% vs avg$60.00
10mg
- 🇺🇸 Ignite Peptides92
✓ verified at source · 23h ago
$6.50/mg -22.4% vs avg$65.00
10mg
- 🇺🇸 Hydro Research Peptides91
✓ verified at source · 23h ago
$6.50/mg -22.4% vs avg$65.00
10mg
Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.
Watch TB-500
Get one email when the market actually moves — no newsletter, no noise.
About TB-500
CAS
885340-08-9
Molecular formula
C38H68N10O14
Sequence
LKKTETQ
Typical dose range
2–5 mg subcutaneous or intramuscular, 1–2x per week; loading phase typically 4–6 weeks
Half-life
~1–2 hours (plasma; based on equine and in vitro studies)
Common research uses
Safety notes
WADA-prohibited (S2 class). Not FDA-approved for human therapeutic use.
Reconstitution
Reconstitute with bacteriostatic water; stable refrigerated for ~4 weeks.
COAs for TB-500
218 third-party tests across 34 vendors. Each card links to the full report.
For
TB-500(TB-4)
by Ignite Peptides· batch IP-2607-898
For
TB-500
by NG Peptide· batch TB10-08
For
TB-500
by EZ Peptides· batch EZP-TBF1006172026-06
For
TB-500
by Ion Peptide· batch TB10-06092026
For
TB-500
by Ion Peptide· batch TB10-06092026
For
TB-500
by EZ Peptides· batch EZP-TBF1005142026-05
For
TB-500 (TB4)
by Peptide Partners· batch SPL-3956
For
TB-500
by Prime Peptides· batch 4142026TB
For
TB-500 (Tβ4)
by Moglabs· batch TB002
For
TB-500 (Tβ4)
by Arcane Peptides· batch TB002
For
TB-500 (TB4)
by Arcane Peptides· batch TB002
For
TB-500 (TB4)
by Moglabs· batch TB002
For
TB-500
by Ion Peptide· batch TB20-05072026
For
TB-500
by Prime Peptides· batch 4062026TB
For
TB-500
by Verified Peptides· batch TB042609101
For
TB-500
by Verified Peptides· batch FTB06260510E
For
TB-500
by Verified Peptides· batch FTB06260510E
For
Frag(17-23) TB-500
by Verified Peptides· batch FTB0626Q510E
For
TB-500
by NG Peptide· batch TB20-5
For
TB-500
by Ion Peptide· batch TB10-05042026
For
TB-500
by Ion Peptide· batch TB-0504/2026
For
TB-500
by Ion Peptide· batch COA-2026-1IWW6J
For
TB-500
by NG Peptide· batch TB10-07
For
Frag(17-23) TB-500
by Verified Peptides
15 citations indexed for TB-500
review · 2026
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Background Peptide therapeutics represent an emerging frontier in gerontological medicine, targeting fundamental hallmarks of aging including metabolic dysfunction, telomere attrition, tissue repair impairment, and hormonal decline.
review · 2026
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement.
review · 2026
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
Background Therapeutic peptides are short-chain amino acids that regulate cellular functions and facilitate biochemical processes. In recent years, there has been significant growth in the global market for therapeutic peptides and thus its popularity among patients.
review · 2026
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Therapeutic peptides are emerging as promising adjuncts in the management of orthopaedic injuries, grounded in their ability to modulate molecular signaling networks central to cellular medicine.
review · 2026
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives
Therapeutic peptides are short chains of amino acids used to treat metabolic and endocrine conditions such as obesity and type 2 diabetes.
rct · 2026
TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD
This fictional study is an example of a ClinicalTrials.gov-style record. It describes a Phase 1/2 trial evaluating the safety and tolerability of TB-500 (a 17-23 fragment of thymosin beta 4) versus placebo in adults with stable atherosclerotic cardiovascular disease (ASCVD).
Research use only — not for human consumption and not approved by the FDA. Nothing here is medical advice.